本页面由Tiger Trade Technology Pte. Ltd.提供服务

美国血液技术

108.40
-0.4000-0.37%
盘后108.400.00000.00%19:30 EDT
成交量:64.11万
成交额:6,940.00万
市值:49.26亿
市盈率:52.88
高:109.49
开:108.02
低:107.38
收:108.80
52周最高:109.57
52周最低:47.32
股本:4,544.60万
流通股本:4,459.72万
量比:0.56
换手率:1.44%
股息:- -
股息率:- -
每股收益(TTM):2.05
每股收益(LYR):2.05
净资产收益率:11.20%
总资产收益率:6.60%
市净率:5.89
市盈率(LYR):52.88

数据加载中...

公司资料

公司名字:
美国血液技术
交易所:
NYSE
成立时间:
1971
员工人数:
3009
公司地址:
125 Summer Street,Boston,Massachusetts,United States
邮编:
02110
电话:
传真:
- -
简介:
Haemonetics Corporation于1971年根据马萨诸塞州法律成立,是一家医疗器械公司。该公司是一家致力于提高医疗保健质量、效果和效率的全球医疗技术公司,运营三个主要报告分部:血浆、血库和医院。公司的创新解决方案包括医院技术、端到端血浆采集技术以及帮助血库采集急需血液成分的产品。

董事

名称
职位
Christopher Simon
Director,Chief Executive Officer and President
Claire Pomeroy
Independent Director
Diane M. Bryant
Independent Director
Ellen M. Zane
Chair of the Board and Independent Director
Lloyd E. Johnson
Independent Director
Mark W. Kroll
Independent Director
Michael J. Coyle
Independent Director
Robert Abernathy
Independent Director

股东

名称
职位
Christopher Simon
Director,Chief Executive Officer and President
Frank W. Chan
Chief Operating Officer and Executive Vice President
James C. D'Arecca
Executive Vice President, Chief Financial Officer
Laurie A. Miller
Chief Human Resources Officer and Senior Vice President
Michelle Basil
Executive Vice President and General Counsel
Roy Galvin
Executive Vice President, Chief Commercial Officer